Loading…
Caplin Point Laboratories (CAPLIPOINT)₹2,503+1.84%Pharmaceuticals
At the end of the Jun 2026 quarter, Caplin Point Laboratories' shareholders were: promoters 70.51%, FIIs 5.73%, DIIs 2.48%, public 21.28%. Promoter holding is unchanged on the quarter. FII holding is down 0.40 percentage points from 6.13% a year earlier. It had 94,409 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.56% | 70.56% | 70.56% | 70.50% | 70.50% | 70.50% | 70.50% | 70.50% | 70.51% | 70.51% | 70.51% | 70.51% |
| FIIs | 3.07% | 2.82% | 3.31% | 3.36% | 3.69% | 4.83% | 5.70% | 6.13% | 6.48% | 6.55% | 6.12% | 5.73% |
| DIIs | 0.21% | 0.43% | 1.07% | 1.48% | 1.82% | 2.10% | 1.99% | 2.21% | 2.09% | 2.04% | 2.13% | 2.48% |
| Public | 26.16% | 26.19% | 25.06% | 24.66% | 23.99% | 22.57% | 21.81% | 21.16% | 20.92% | 20.90% | 21.24% | 21.28% |
| Number of shareholders | 78,088 | 79,459 | 81,430 | 80,432 | 96,148 | 92,726 | 96,412 | 94,193 | 93,777 | 93,729 | 93,920 | 94,409 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| P Vijayalakshmi | Promoter | 24.67% | 0.00 |
| Paarthipan C C | Promoter | 18.67% | 0.00 |
| Ashok Gorkey Partheeban | Promoter | 11.90% | 0.00 |
| Partheeban Vivek Siddarth | Promoter | 11.86% | 0.00 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | Public | 2.84% | −0.17 |
| May India Property Private Limited | Promoter | 2.76% | 0.00 |
| Uti Multi Cap Fund | DII | 1.82% | −0.04 |
| Pinebridge Global Funds - Pinebridge India Equity Fund | FII | 1.04% | 0.00 |
| First Dimension Holdings Private Limited | Promoter | 0.49% | 0.00 |
| Kiraviz Properties And Consultancy Llp | Promoter | 0.20% | 0.00 |
Promoters held 70.51% of Caplin Point Laboratories at the end of the Jun 2026 quarter, up 0.01 percentage points from 70.50% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 5.73% (down 0.39 percentage points from 6.12% a quarter earlier) and domestic institutions (DIIs) held 2.48% (up 0.35 percentage points from 2.13% a quarter earlier).
Caplin Point Laboratories had 94,409 shareholders at the end of the Jun 2026 quarter, against 94,193 a year earlier.
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs (Public) held 2.84% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.